Real-world comparison of bleeding risks among non-valvular atrial fibrillation patients prescribed apixaban, dabigatran, or rivaroxaban

Limited real-world data are available regarding the comparative safety of non-vitamin K antagonist oral anticoagulants (NOACs). The objective of this retrospective claims observational cohort study was to compare the risk of bleeding among non-valvular atrial fibrillation (NVAF) patients prescribed...

Full description

Saved in:
Bibliographic Details
Published in:PLoS One
Main Authors: Tepper, Ping G., Mardekian, Jack, Masseria, Cristina, Phatak, Hemant, Kamble, Shital, Abdulsattar, Younos, Petkun, William, Lip, Gregory Y. H.
Format: Artigo
Language:Inglês
Published: Public Library of Science 2018
Subjects:
Research Article
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC6211674/
https://ncbi.nlm.nih.gov/pubmed/30383768
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1371/journal.pone.0205989
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items